Currently, Narayan is involved in key projects such as the ACT-South Asia Trial (Azithromycin and Cefixime Treatment of Typhoid), ACORN – Phase 2, and ACORN-HAI, which focus on hospital-acquired infections and antimicrobial resistance surveillance. His insatiable thirst for knowledge and steadfast dedication to microbial discovery are central to his mission of advancing public health through research and evidence-based interventions.
